I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Cohen, Aileen
164
results:
Format
Online (164)
Mediatypes
Articles (Online) (72)
OpenAccess-fulltext (91)
Audio (Online) (1)
Sorted by: Relevance
Sorted by: Year
?
1
Cardiovascular events reported in patients with B-cell mali..:
Moslehi, Javid J.
;
Furman, Richard R.
;
Tam, Constantine S.
...
Blood Advances. 8 (2024) 10 - p. 2478-2490 , 2024
Link:
https://doi.org/10.1182/..
?
2
Characterization of zanubrutinib safety and tolerability pr..:
Brown, Jennifer R.
;
Ghia, Paolo
;
Jurczak, Wojciech
...
Haematologica. , 2024
Link:
https://doi.org/10.3324/..
?
3
Similar efficacy of ibrutinib arms across ALPINE and ELEVAT..:
Shadman, Mazyar
;
Tedeschi, Alessandra
;
Mohseninejad, Leyla
...
Blood Cancer Journal. 14 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1038/..
?
4
Plain language summary of zanubrutinib or ibrutinib in chro..:
Brown, Jennifer R
;
Eichhorst, Barbara
;
Hillmen, Peter
...
Future Oncology. 20 (2024) 12 - p. 717-726 , 2024
Link:
https://doi.org/10.2217/..
?
5
Genomic landscape of patients in a phase II study of zanubr..:
Xu, Linlin
;
Shadman, Mazyar
;
Flinn, Ian W.
...
Haematologica. , 2024
Link:
https://doi.org/10.3324/..
?
6
P1136: FIRST INTERIM ANALYSIS OF A PHASE 1 STUDY OF ZANUBRU..:
Zhang, Huilai
;
Cheng, Ying
;
Yang, Hai-Yan
...
HemaSphere. 7 (2023) S3 - p. e1828304 , 2023
Link:
https://doi.org/10.1097/..
?
7
Zanubrutinib in patients with treatment‐naïve or relapsed/r..:
Castillo, Jorge J
;
Kingsley, Edwin C
;
Narang, Mohit
...
eJHaem. 4 (2023) 1 - p. 301-304 , 2023
Link:
https://doi.org/10.1002/..
?
8
Zanubrutinib, Alone and in Combination With Tislelizumab, f..:
Tam, Constantine
;
Munoz, Javier
;
Cull, Gavin
...
HemaSphere. 7 (2023) 4 - p. e870 , 2023
Link:
https://doi.org/10.1097/..
?
9
A Phase 1, Open‐Label, Fixed‐Sequence, Drug–Drug Interactio..:
Tariq, Bilal
;
Conto, Stephanie
;
Cohen, Aileen
..
Clinical Pharmacology in Drug Development. 12 (2023) 8 - p. 832-838 , 2023
Link:
https://doi.org/10.1002/..
?
10
P631: CHARACTERIZATION OF ZANUBRUTINIB SAFETY/TOLERABILITY ..:
Brown, Jennifer R.
;
Eichhorst, Barbara
;
Ghia, Paolo
...
HemaSphere. 7 (2023) S3 - p. e356884b , 2023
Link:
https://doi.org/10.1097/..
?
11
Intrinsically disordered regions of the Msn2 transcription ..:
Mindel, Vladimir
;
Brodsky, Sagie
;
Cohen, Aileen
...
Nucleic Acids Research. 52 (2023) 5 - p. 2260-2272 , 2023
Link:
https://doi.org/10.1093/..
?
12
P633: UPDATED SAFETY AND EFFICACY RESULTS OF ZANUBRUTINIB I..:
Shadman, Mazyar
;
Y. Levy, Moshe
;
Porter, Ryan
...
HemaSphere. 7 (2023) S3 - p. e70152b3 , 2023
Link:
https://doi.org/10.1097/..
?
13
P1679: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS (PTS) WIT..:
Tedeschi, Alessandra
;
Tam, Constantine
;
Owen, Roger
...
HemaSphere. 7 (2023) S3 - p. e27391ea , 2023
Link:
https://doi.org/10.1097/..
?
14
PB1926: EFFICACY AND SAFETY OF ONCE DAILY (QD) VS TWICE DAI..:
Tam, Constantine
;
Shadman, Mazyar
;
Sharman, Jeff
...
HemaSphere. 7 (2023) S3 - p. e70124b5 , 2023
Link:
https://doi.org/10.1097/..
?
15
IBCL-117 ASPEN: Long-Term Follow-Up Results of a Phase 3 Ra..:
Castillo, Jorge J.
;
Tam, Constantine S.
;
Garcia-Sanz, Ramon
...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S385 , 2022
Link:
https://doi.org/10.1016/..
1-15